Saturday 17 October 2026
Export SCL’s income statement to Excel — free account
Stepan Company
SCL Basic Materials Specialty Chemicals
Stepan Company’s revenue for fiscal 2025 (year ended December 2025) was $2.3 billion, up 6.96% from fiscal 2024. In the quarter to June 2026, revenue grew 15.0%, EPS grew 100.0%, free cash flow fell 4.42% and total debt fell 1.62%, each against the same quarter a year earlier. Dividend growth for ten consecutive years.
62.03
0.16
+0.26%
Follow SCL
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (0.22%) | (1.19%) | 3.89% | 3.67% |
+8 more TTM periods Free account |
|
Piotroski F-Score |
4 | 4 | 5 | 5 | |
| (0.11%) | (0.60%) | 2.01% | 1.87% | ||
ROIC |
0.71% | 0.02% | 2.82% | 2.65% | |
Return on Tangible Assets |
(0.21%) | (1.07%) | 3.32% | 3.17% | |
Average Days of Receivables |
73.87 | 67.55 | 60.72 | 69.10 | |
Free Cash Flow per Share |
2.76 | 2.79 | 2.27 | 1.40 | |
Free Cash Flow |
63.17 | 63.81 | 51.96 | 32.08 | |
Capital Expenditures |
(91.87) | (94.07) | (95.93) | (124.10) | |
| Other line items | |||||
Cash ROIC |
3.20% | 3.21% | 2.59% | 1.59% | |
Accounts Receivable Turnover |
5.21 | 5.39 | 6.01 | 5.29 | |
Accounts Payable Turnover |
7.11 | 7.14 | 7.92 | 7.43 | |
Inventory Turnover |
6.56 | 6.97 | 7.02 | 6.53 | |
Average Days of Payables |
54.72 | 50.04 | 46.32 | 52.06 | |
Days of Inventory on Hand |
55.20 | 50.62 | 52.89 | 58.34 | |
Tax Rate |
4.46 | (0.26) | (0.22) | (0.21) | |
Research and Development Expense of Revenue |
2.55% | 2.54% | 2.54% | 2.49% | |
Selling, General and Administrative Expense of Revenue |
5.94% | 6.11% | 6.08% | 6.16% | |
Share Based Compensation of Revenue |
0.27% | 0.26% | 0.26% | 0.23% | |
Interest Coverage |
0.86 | 0.03 | 3.55 | 3.56 | |
Operating CF/Net income |
(58.46) | (11.10) | 3.15 | 3.45 | |
Depreciation/Fixed assets |
0.11 | 0.11 | 0.10 | 0.10 | |
Capex/Depreciation |
(0.71) | (0.73) | (0.76) | (1.02) | |
Revenue per Share |
106.25 | 102.38 | 101.96 | 100.71 | |
Operating CF per Share |
6.77 | 6.90 | 6.47 | 6.83 | |
Capex per Share |
(4.01) | (4.11) | (4.19) | (5.43) | |
Capex to Sales |
0.04 | 0.04 | 0.04 | 0.05 |
Columns are period end dates